DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @Gambiste1 | 19 |
| @Tickeron | 15 |
| @sleekoptions | 14 |
| @AmericanBanking | 10 |
| @DataTrials | 10 |
Recent Tweets for INCY
 |
@Gambiste1 RT @weygand_gmt: #Incyte Targets: 88,83 and 96,44 USD $INCY #Biotech #Aktien #Equities https://t.co/JDafjsfyU9 November 10th 2019, 6:11pm |
 |
@weygand_gmt #Incyte Targets: 88,83 and 96,44 USD $INCY #Biotech #Aktien #Equities https://t.co/JDafjsfyU9 November 10th 2019, 4:11pm |
|
@Gambiste1 RT @BayAreaBiotechI: $INCY was an aberration, does that mean $NKTR is? #SITC19 https://t.co/hWuugFKEIM November 10th 2019, 11:11am |
|
@Gambiste1 RT @KayatekinCan: Reminder of the $INCY IDO data. $NKTR seems to have deeper responses fwiw. https://t.co/ft4Lvo8t43 November 10th 2019, 8:11am |
 |
@StockTipRobot Buy! Sell! No buy! On second thought, sell! Actually just stop buying Incyte $INCY #money November 10th 2019, 8:11am |
 |
@Tickeron $INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators:… https://t.co/2sPiAaYtSq November 10th 2019, 8:11am |
 |
@KayatekinCan Reminder of the $INCY IDO data. $NKTR seems to have deeper responses fwiw. https://t.co/ft4Lvo8t43 November 10th 2019, 8:11am |
 |
@Hall8Jack RT @edtaussig: $NKTR $INCY https://t.co/oidSO66afi "Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combi… November 10th 2019, 7:11am |
 |
@WatchlistN Incyte Co. $INCY Director Wendy L. Dixon Sells 10,576 Shares https://t.co/4Fb0xYXj8U November 10th 2019, 6:11am |
 |
@TranscriptDaily Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/2n0CeLrqKV November 10th 2019, 5:11am |
 |
@EnterpriseLeade Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares https://t.co/qKYq6H43Ad November 10th 2019, 5:11am |
 |
@edtaussig $NKTR $INCY https://t.co/oidSO66afi "Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination" November 10th 2019, 2:11am |
 |
@BayAreaBiotechI $INCY was an aberration, does that mean $NKTR is? #SITC19 https://t.co/hWuugFKEIM November 10th 2019, 12:11am |
|
@Gambiste1 RT @thestaghound: @Dr_Aggen This is awful $INCY November 9th 2019, 11:11pm |
 |
@thestaghound @Dr_Aggen This is awful $INCY November 9th 2019, 11:11pm |
 |
@Miljenkoz @AndyBiotech Andy, with that comparison you tunked more than REGULAR BULLSHITER! $NKTR $INCY November 9th 2019, 8:11pm |
|
@Gambiste1 RT @gcassidy718: $INCY this is the time you buy equities thank you fed 2.83 % change recently https://t.co/n8cAMFdPkt November 9th 2019, 8:11pm |
 |
@gcassidy718 $INCY this is the time you buy equities thank you fed 2.83 % change recently https://t.co/n8cAMFdPkt November 9th 2019, 7:11pm |
|
@Tickeron $INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators:… https://t.co/9cMquJIYfm November 9th 2019, 9:11am |
 |
@ZolmaxNews Insider Selling: Incyte Co. $INCY Director Sells 41,218 Shares of Stock https://t.co/l2Io34qMGr November 9th 2019, 8:11am |
 |
@dailypoliticaln Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares of Stock https://t.co/YkJ5I5sjGS November 9th 2019, 8:11am |
 |
@MonitorAction $INCY Wendy Dixon sells $3.5M Worth Of Incyte Stock https://t.co/tRadk7lSjv November 8th 2019, 10:11pm |
 |
@AmericanBanking Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/jg1EeSsNZt #stocks November 8th 2019, 7:11pm |
|
@AmericanBanking Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/6YkpkRmeji #stocks November 8th 2019, 7:11pm |
 |
@ConsumerFeed Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/lB6PsNHp4v November 8th 2019, 7:11pm |
 |
@InsiderAlertsIA $INCY: New Insider Filing on Director WENDY L DIXON: https://t.co/3m8IEaGzA5 November 8th 2019, 5:11pm |
 |
@RTFilingsStocks DIXON WENDY L files Form 4 for $INCY Sold 53334 shares Price range: $83.6-84.16 Transaction Dates: 11/6/2019-11/8/2… https://t.co/KIDshrYpYL November 8th 2019, 5:11pm |
 |
@ActionTrading1 $INCY 4 Hours https://t.co/Qe68CjCtHm November 8th 2019, 4:11pm |
|
@ActionTrading1 $INCY Hourly https://t.co/LjSKMjfROV November 8th 2019, 4:11pm |
|
@Tickeron $INCY in Uptrend: Stochastic indicator stays in overbought zone for 6 days. View odds for this and other indicators… https://t.co/xbLv7vI7AL November 8th 2019, 12:11pm |
 |
@Wolfmetric $INCY strong red-to-green move today November 8th 2019, 11:11am |
|
@ActionTrading1 $INCY Hourly https://t.co/9Nq6Dctni6 November 8th 2019, 7:11am |
|
@ActionTrading1 $INCY 4 Hours https://t.co/X8v2ha141D November 8th 2019, 7:11am |
 |
@bbnsnews Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/efobeRcB9F November 8th 2019, 5:11am |
 |
@WeekHerald Incyte Co. $INCY Insider Sells $722,500.00 in Stock https://t.co/sJtQ25szw9 November 8th 2019, 5:11am |
 |
@sleekoptions $INCY Was up 1.11 %. Turned negative -1.10 % | (Green to red move) https://t.co/ksN8HlN6pO https://t.co/GczHogVYAB November 7th 2019, 9:11pm |
|
@sleekoptions $INCY Was up 1.11 %. Turned negative -0.82 % | (Green to red move) https://t.co/ksN8HlN6pO https://t.co/F12iyLekAe November 7th 2019, 2:11pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $INCY? The Short Ratio is 4.77% https://t.co/oNwLaFBWtL November 7th 2019, 2:11pm |
 |
@AlertTrade TREND REVERSAL DOWN ALERT: $INCY Incyte Corporation Common Stock ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room November 7th 2019, 1:11pm |
 |
@StockTexts $INCY Incyte Corporation SEC Filing: Form CT ORDER https://t.co/yNNicH45cR November 7th 2019, 1:11pm |
 |
@Stock_News_Now $INCY: New SEC Filing for INCY: Form CT ORDER (No. 9999999997-19-007466): https://t.co/CnVjdLAAPI November 7th 2019, 1:11pm |
 |
@ProTradersNews $INCY: Here’s Why Incyte Corporation Jumped 13.0% in October: https://t.co/z7W8RtbU1l November 7th 2019, 12:11pm |
|
@Tickeron $INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this… https://t.co/CyUHgD7UA0 November 7th 2019, 8:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 1 Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies…NCT01905813. Estimated Primary Co… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 1|Phase 2 A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refract… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 1|Phase 2 A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 1|Phase 2 A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib…NCT01… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 2 A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 2 A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cel… November 7th 2019, 7:11am |
|
@Gambiste1 RT @DataTrials: $INCY Phase 1 INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previ… November 7th 2019, 7:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.